Resonetics Announces Recapitalization with GTCR’s Regatta Medical
February 01, 2018 || RESONETICS || RECENT NEWS
Regatta Medical to Support Growth of Market-Leader in Micromanufacturing for the Life Sciences
Resonetics announced today that Regatta Medical has made a strategic investment in Resonetics. Led by CEO Chip Hance, Regatta Medical is a portfolio company of GTCR, a leading private equity investor in the healthcare sector. Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.